[Clinical experiences with the analgesic effects of citalopram].
Antidepressive drugs influencing the serotonin metabolism have shown some efficacy in treatment of generalised pain syndrome. The aim of the present study was to observe the analgesic effect of citalopram < 1-[3-(dimetilamino)propil]-1-(p-florofenil)-5-ftal+  ++ánkarbonitin > in 20 non depressive patients with chronic pain syndrome (fibromyalgy and/or radicular pain). On the base of a short time (6 weeks) observation a limited clinical effect was observed, however, the Seropram seems to have some benefits in the treatment of chronic pain.
Baraczka
K
K
Országos Reumatológiai és Fizioterápiás Intézet, Budapest.
Jankó
Z
Z
Vargha
K
K
Márkus
H
H
D000700:Analgesics / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D002908:Chronic Disease; D015283:Citalopram / Q000627:therapeutic use*; D005356:Fibromyalgia / Q000188:drug therapy; D006801:Humans; D010146:Pain / Q000188:drug therapy*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D014277:Trigeminal Neuralgia / Q000188:drug therapy
D000700:Analgesics; D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors